What is CheqUp?

CheqUp is a CQC-regulated digital weight loss provider offering prescription medication alongside dedicated health coaching. Founded as a clinician-led GLP-1 service, it has grown to become one of the more visible providers in the UK private weight loss market.
The company is registered with the Care Quality Commission, and dispenses through its own GPhC-registered pharmacy, with CloudRx used as a secondary dispensing pharmacy in some cases. CheqUp offers Mounjaro and Wegovy injections, alongside Alli (orlistat), a non-prescription fat-absorption tablet.
CheqUp operates entirely online. There are no physical clinics – consultations, prescribing, coaching and ongoing support all happen through the website and app. The company states it is a recommended NHS supplier of weight management services and holds NHS Digital Technology Accreditation Criteria (DTAC) certification, alongside Cyber Essentials and Data Security and Protection Toolkit accreditations.

What is included in the programme

CheqUp’s weight loss programme combines prescription medication with unlimited one-to-one health coaching, positioned as a core part of the service rather than an add-on. Members get access to dedicated Health Coaches for nutrition, exercise and general support, alongside ongoing contact with the clinical team for dose adjustments and medical questions.
The app includes food, weight and activity tracking, alongside symptom logging. CheqUp states that members who actively use both their Health Coach and the tracking app lose more weight over six months than the wider customer base, based on the company’s own internal data.
CheqUp has also partnered with WeightWatchers to offer a GLP-1 Companion Programme, combining medication support with WeightWatchers’ established behaviour-change tools – a notable point of difference from most competitors, who build coaching entirely in-house.
Subscriptions renew every 28 days, with discounts available on three and six month plans for patients who commit to a longer programme upfront.

The consultation process

CheqUp’s process begins with an online health questionnaire covering medical history, current medications, weight and weight loss goals. This is reviewed by the clinical team, led by a GMC-registered prescriber, who determines whether treatment is clinically appropriate.
As part of identity and eligibility verification, CheqUp requires ID checks and full-body photos as part of onboarding – a more thorough verification step than some competitors, reflecting tightened GPhC requirements introduced in February 2025 for online weight-loss prescribing, which require independently verified weight, height and BMI rather than self-reported figures alone.
As with most digital weight loss providers, there is no default video consultation built into the standard pathway, though patients can contact clinicians and coaches directly once enrolled. If an application is declined at the questionnaire stage, CheqUp states orders are cancelled and refunded in full automatically.

Pricing breakdown

CheqUp’s entry-level pricing sits toward the more competitive end of the UK private market compared with several established providers, though as with all providers in this market, the headline starting price reflects the lowest dose rather than the likely cost of ongoing treatment at a maintenance dose.
CheqUp also offers discounted pricing on three and six month plans, which lowers the effective monthly cost for patients willing to commit upfront rather than pay month to month.
For current prices across all doses, see our Mounjaro UK price comparison table, checked weekly.

The good – genuine strengths

CheqUp’s unlimited one-to-one health coaching is a genuine differentiator, built into every plan rather than offered as a paid add-on. Independent reviews consistently single out the quality of named coaches and clinicians as a strength, suggesting the coaching model is delivered in practice rather than existing only in marketing copy.
The WeightWatchers partnership is a distinctive offering not matched by most competitors, giving patients access to an established, well-known behaviour-change framework alongside medication, rather than a wholly in-house coaching programme built from scratch.
CheqUp’s entry-level pricing is competitive against several established providers, see our live Mounjaro price comparison for exactly where it sits today, and the availability of discounted three and six month plans gives patients a way to reduce costs further if they’re confident in committing to longer-term treatment.
The regulatory and clinical framework is solid – CQC registered, GPhC-registered dispensing pharmacy, GMC-registered prescribing lead – and CheqUp’s identity verification process is notably more thorough than some competitors, which is a genuine safety positive given ongoing GPhC concern about online weight-loss prescribing standards.
CheqUp’s status as a recommended NHS supplier of weight management services and its NHS DTAC accreditation are also worth noting as independent indicators of clinical and technical standards, beyond the baseline CQC/GPhC registration most providers can claim.

The not so good – honest weaknesses

In late 2025, the Advertising Standards Authority upheld two separate complaints against CheqUp, both worth knowing about. The first concerned a Facebook ad seen in July 2025. The ASA found the ad breached the CAP Code’s rules on advertising medicines to the public, because its landing page named Mounjaro and Wegovy – both prescription-only medicines – in a way the regulator considered equivalent to advertising those specific drugs directly to consumers, after consulting the MHRA on the point.
The second, separate complaint concerned a different Facebook ad, seen later the same month, which featured an image of a woman looking at herself in a mirror alongside the text “I don’t want to be skinny. I just don’t want to be the biggest person in the room.” The ASA ruled this ad was irresponsible because it exploited people’s insecurities around body image, a finding distinct from the prescription-medicine issue above. CheqUp told the ASA it had deliberately chosen to feature someone who appeared overweight rather than at a healthy weight, with the intention of promoting healthy rather than unrealistic goals, but the complaint was upheld regardless.
CheqUp’s response on the first issue was that the ad pre-dated a September 2025 CAP enforcement notice clarifying this exact point industry-wide, that the practice wasn’t clearly understood to breach the Code before that notice, and that the ad had not run since August 2025. CheqUp also stated its landing pages have since been revised to comply with CAP and ASA guidance.
These are findings about advertising practices, not about the safety or quality of CheqUp’s clinical service – the same distinction that applied to a similar finding against a competitor covered elsewhere on this site. They’re still worth knowing about, since together they reflect on the company’s marketing standards at the time, even if the specific issues have reportedly been corrected.
A further point worth flagging: CheqUp’s own published materials show two different GPhC pharmacy registration numbers in different places (9012707 and 9012563), most likely reflecting a pharmacy change over time rather than anything more concerning, but it’s a discrepancy worth being aware of. Rather than rely on either figure, it’s worth searching “CheqUp” or “Chequp Health” directly on the GPhC register to confirm the current dispensing pharmacy before signing up.
As with most competitors, the headline entry price doesn’t reflect the cost at higher maintenance doses, and patients should check the full pricing schedule for the dose they’re likely to reach over time before committing.

Who CheqUp suits best

CheqUp works well for patients who want genuinely included, unlimited coaching support as standard, rather than as a separate paid extra, and who value having a named coach they can return to repeatedly throughout treatment.
It also suits patients who like the idea of combining medication with an established behaviour-change framework, given the WeightWatchers partnership – particularly anyone who has used WeightWatchers before and trusts its approach.
Patients prioritising lower entry-level pricing, especially for Wegovy, may also find CheqUp competitive against several established providers, particularly if they’re comfortable committing to a three or six month plan to lock in a lower rate.

Who CheqUp probably does not suit

CheqUp is less suitable for patients who place significant weight on a provider’s regulatory and advertising track record, since the 2025 ASA ruling, while resolved according to CheqUp, is a real mark against the company’s marketing practices that some patients may want to factor into their decision.
Patients who find the more thorough ID verification process (including full-body photos) intrusive or uncomfortable may prefer a provider with a lighter-touch onboarding process, even though CheqUp’s approach reflects genuine GPhC safety guidance rather than being excessive for its own sake.
People who want the reassurance of a single, clearly stated GPhC pharmacy number across all of a provider’s materials, rather than having to independently verify which of two published numbers is current, may find the discrepancy in CheqUp’s own documentation an unnecessary source of friction, however minor.

How to verify CheqUp is legitimate

Before signing up to any private weight loss service, two checks protect you.
CQC registration: search for CheqUp Health Limited on the Care Quality Commission register – the provider ID is 1-17083303713 – to confirm current registration status.
GPhC registration: CheqUp’s own published materials show two different GPhC pharmacy registration numbers in different places, likely reflecting a pharmacy change over time. Rather than rely on either figure, search “CheqUp” or “Chequp Health” directly on the General Pharmaceutical Council register to confirm the current dispensing pharmacy.
You can also read the full ASA ruling on CheqUp’s 2025 Facebook advertisement directly at asa.org.uk – search “Chequp Health Ltd” in the ASA rulings archive.

Verdict

CheqUp is a legitimate, CQC-registered service offering licensed weight loss medications with a genuinely strong coaching model built into every plan, backed by a distinctive WeightWatchers partnership that sets it apart from most competitors in this comparison.
The caveats are worth weighing honestly. The 2025 ASA ruling on advertising standards is a real finding, even though CheqUp states the issue has since been corrected, and the inconsistency across its own published GPhC registration numbers, while likely just an administrative oversight, is the kind of detail that should be tidied up and is worth verifying independently before signing up.
For patients who want strong, included coaching and are drawn to the WeightWatchers partnership, CheqUp is a credible option with competitive entry pricing. For patients who weight a clean advertising and regulatory record heavily, the 2025 ruling is worth factoring into the decision alongside everything else this review covers.

Frequently Asked Questions

This review is for information purposes only. ThePeptideBrief does not receive payment from CheqUp or any other clinic for editorial coverage. Always conduct your own research before committing to any private health service.